Clinical trial
Liposomal Vincristine in Treating Patients With Refractory or Relapsed…
NCT00006383 · Inex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00006383 |
|---|---|
| Title | Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma |
| Official title | Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Diffuse Large B-Cell Non-Hodgkin's Lymphoma That is Refractory or Relapsed After Second-Line Combination Chemotherapy Revised Title Per 03/01 SR Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes… |
| Lead sponsor | Inex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | liposomal vincristine sulfate |
| Start date | Jun 1, 2000 |
| Completion | Aug 1, 2009 |
| First posted | May 30, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: